Skip Navigation
Skip to contents

J Pathol Transl Med : Journal of Pathology and Translational Medicine

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
22 "Jong Sil Lee"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Case Study
Intravascular NK/T-cell lymphoma: a case report and literature review
Ji Min Na, Wookjae Jung, Minhye Kim, Yun-Hong Cheon, Jong Sil Lee, Dae Hyun Song, Jung Wook Yang
J Pathol Transl Med. 2023;57(6):332-336.   Published online November 14, 2023
DOI: https://doi.org/10.4132/jptm.2023.10.30
  • 848 View
  • 170 Download
  • 1 Web of Science
  • 1 Crossref
AbstractAbstract PDF
Intravascular lymphoma is characterized by an exclusively intravascular distribution of tumor cells. Intravascular natural killer/T-cell lymphoma (IVNKTL) is extremely rare, highly aggressive, commonly Epstein-Barr virus (EBV)–positive, and predominantly affects the skin and central nervous system. Here we report a case of IVNKTL diagnosed in a 67-year-old female, presenting with persistent intermittent fever and skin rashes throughout the body. Incisional biopsy of an erythematous lesion on the chest exhibited aggregation of medium to large-sized atypical lymphoid cells confined to the lumen of small vessels that were positive for CD3, granzyme B, and CD56 on immunohistochemistry and EBV-encoded RNA in situ hybridization. EBV DNA was also detected in serum after diagnosis. With a review of 26 cases of IVNKTL to date, we suggest that active biopsy based on EBV DNA detection may facilitate early diagnosis of IVNKTL.

Citations

Citations to this article as recorded by  
  • Cutaneous Intravascular Hematolymphoid Entities: A Review
    Emily Hatheway Marshall, Bethany Brumbaugh, Allison Holt, Steven T. Chen, Mai P. Hoang
    Diagnostics.2024; 14(7): 679.     CrossRef
Original Articles
Correlation between myoferlin expression and lymph node metastasis in papillary thyroid carcinoma
Ji Min Na, Dong Chul Kim, Dae Hyun Song, Hyo Jung An, Hyun Min Koh, Jeong-Hee Lee, Jong Sil Lee, Jung Wook Yang, Min Hye Kim
J Pathol Transl Med. 2022;56(4):199-204.   Published online May 11, 2022
DOI: https://doi.org/10.4132/jptm.2022.03.19
  • 2,768 View
  • 165 Download
AbstractAbstract PDF
Background
Myoferlin is a multifunctional protein expressed in various normal and cancer cells, with novel oncogenic roles being newly discovered. Recently, correlations have been found between myoferlin expression and unfavorable prognosis in various carcinomas. This study investigated the prognostic role of myoferlin expression in papillary thyroid carcinoma (PTC), specifically that associated with nodal metastasis.
Methods
We collected clinicopathological data and PTC tissues from 116 patients who had been admitted to Gyeongsang National University Hospital in 2010. Immunohistochemical analysis was performed on surgical specimen-derived tissue microarray blocks. Myoferlin expression was graded, and the relationship between expression level and pathological features of tumors based on the American Joint Committee on Cancer staging system was evaluated.
Results
Of the 116 patient samples, 100 cases exhibited positive myoferlin expression. Higher grade of myoferlin expression was correlated with lower T category group (p = .010). Presence of lymph node metastasis was determined to be significantly correlated with low-grade myoferlin expression (p = .019), with no significant difference between pN1a and pN1b tumors.
Conclusions
Our study revealed an adverse correlation between myoferlin expression and pathological features of PTC, evidence of the potential prognostic role of myoferlin in PTC lymph node metastasis.
Prognostic Role of S100A8 and S100A9 Protein Expressions in Non-small Cell Carcinoma of the Lung
Hyun Min Koh, Hyo Jung An, Gyung Hyuck Ko, Jeong Hee Lee, Jong Sil Lee, Dong Chul Kim, Jung Wook Yang, Min Hye Kim, Sung Hwan Kim, Kyung Nyeo Jeon, Gyeong-Won Lee, Se Min Jang, Dae Hyun Song
J Pathol Transl Med. 2019;53(1):13-22.   Published online November 26, 2018
DOI: https://doi.org/10.4132/jptm.2018.11.12
  • 6,643 View
  • 236 Download
  • 12 Web of Science
  • 10 Crossref
AbstractAbstract PDF
Background
S100A8 and S100A9 have been gaining recognition for modulating tumor growthand metastasis. This study aimed at evaluating the clinical significance of S100A8 and S100A9 innon-small cell lung cancer (NSCLC).
Methods
We analyzed the relationship between S100A8and S100A9 expressions, clinicopathological characteristics, and prognostic significance in tumorcells and peritumoral inflammatory cells.
Results
The positive staining of S100A8 in tumorcells was significantly increased in male (p < .001), smoker (p = .034), surgical method other thanlobectomy (p = .024), squamous cell carcinoma (SQCC) (p < .001) and higher TNM stage (p = .022)compared with female, non-smoker, lobectomy, adenocarcinoma (ADC), and lower stage. Theproportion of tumor cells stained for S100A8 was related to histologic type (p < .001) and patientsex (p = .027). The proportion of inflammatory cells stained for S100A8 was correlated with patientage (p = .022), whereas the proportion of inflammatory cells stained for S100A9 was correlatedwith patient sex (p < .001) and smoking history (p = .031). Moreover, positive staining in tumorcells, more than 50% of the tumor cells stained and less than 30% of the inflammatory cellsstained for S100A8 and S100A9 suggested a tendency towards increased survivability in SQCCbut towards decreased survivability in ADC.
Conclusions
S100A8 and S100A9 expressions might be potential prognostic markers in patients with NSCLC.

Citations

Citations to this article as recorded by  
  • Gene expression related to lung cancer altered by PHMG-p treatment in PBTE cells
    Yoon Hee Park, Sang Hoon Jeong, Hyejin Lee, Cherry Kim, Yoon Jeong Nam, Ja Young Kang, Jin Young Choi, Yu-Seon Lee, Su A. Park, Jaeyoung Kim, Eun-Kee Park, Yong-Wook Baek, Hong Lee, Ju-Han Lee
    Molecular & Cellular Toxicology.2023; 19(1): 205.     CrossRef
  • Discovery of protein biomarkers for venous thromboembolism in non-small cell lung cancer patients through data-independent acquisition mass spectrometry
    Yanhong Liu, Lan Gao, Yanru Fan, Rufei Ma, Yunxia An, Guanghui Chen, Yan Xie
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • S100A8 and S100A9 in Cancer
    Yu Chen, Yuzhen Ouyang, Zhixin Li, Xiufang Wang, Jian Ma
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2023; 1878(3): 188891.     CrossRef
  • Gene expression of S100a8/a9 predicts Staphylococcus aureus-induced septic arthritis in mice
    Meghshree Deshmukh, Santhilal Subhash, Zhicheng Hu, Majd Mohammad, Anders Jarneborn, Rille Pullerits, Tao Jin, Pradeep Kumar Kopparapu
    Frontiers in Microbiology.2023;[Epub]     CrossRef
  • Single-cell immunophenotyping revealed the association of CD4+ central and CD4+ effector memory T cells linking exacerbating chronic obstructive pulmonary disease and NSCLC
    Nikolett Gémes, József Á. Balog, Patrícia Neuperger, Erzsébet Schlegl, Imre Barta, János Fillinger, Balázs Antus, Ágnes Zvara, Zoltán Hegedűs, Zsolt Czimmerer, Máté Manczinger, Gergő Mihály Balogh, József Tóvári, László G. Puskás, Gábor J. Szebeni
    Frontiers in Immunology.2023;[Epub]     CrossRef
  • A Prognostic Gene Signature for Hepatocellular Carcinoma
    Rong Chen, Meng Zhao, Yanli An, Dongfang Liu, Qiusha Tang, Gaojun Teng
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • The S100 protein family in lung cancer
    Ting Wang, Ge Du, Dong Wang
    Clinica Chimica Acta.2021; 520: 67.     CrossRef
  • The associations of serum S100A9 with the severity and prognosis in patients with community-acquired pneumonia: a prospective cohort study
    Hong-Yan Liu, Hui-Xian Xiang, Ying Xiang, Zheng Xu, Chun-Mei Feng, Jun Fei, Lin Fu, Hui Zhao
    BMC Infectious Diseases.2021;[Epub]     CrossRef
  • Saliva proteomic analysis reveals possible biomarkers of renal cell carcinoma
    Xiao Li Zhang, Zheng Zhi Wu, Yun Xu, Ji Guo Wang, Yong Qiang Wang, Mei Qun Cao, Chang Hao Wang
    Open Chemistry.2020; 18(1): 918.     CrossRef
  • Prognostic Role of S100A8 in Human Solid Cancers: A Systematic Review and Validation
    An Huang, Wei Fan, Jiacui Liu, Ben Huang, Qingyuan Cheng, Ping Wang, Yiping Duan, Tiantian Ma, Liangyue Chen, Yanping Wang, Mingxia Yu
    Frontiers in Oncology.2020;[Epub]     CrossRef
Myoferlin Expression and Its Correlation with FIGO Histologic Grading in Early-Stage Endometrioid Carcinoma
Min Hye Kim, Dae Hyun Song, Gyung Hyuck Ko, Jeong Hee Lee, Dong Chul Kim, Jung Wook Yang, Hyang Im Lee, Hyo Jung An, Jong Sil Lee
J Pathol Transl Med. 2018;52(2):93-97.   Published online March 14, 2018
DOI: https://doi.org/10.4132/jptm.2017.11.29
  • 5,920 View
  • 114 Download
  • 10 Web of Science
  • 8 Crossref
AbstractAbstract PDF
Background
For endometrioid carcinoma patients, International Federation of Gynecologists and Obstetricians (FIGO) histologic grading is very important for identifying the appropriate treatment method. However, the interobserver discrepancy with this three-tiered grading system is a serious potential problem. In this study, we used immunohistochemistry to analyze the relationship between FIGO histologic grading score and myoferlin expression.
Methods
We studied the endometrioid carcinoma tissues of 60 patients from Gyeongsang National University Hospital between January 2002 and December 2009. Immunohistochemical analysis of myoferlin was performed on tissue microarray blocks from surgical specimens.
Results
Myoferlin expression was observed in 58 of 60 patients. Moderate and strong myoferlin expression was observed in low-grade endometrioid carcinoma, while there was a tendency toward loss of myoferlin expression in high-grade endometrioid carcinoma (p<.001).
Conclusions
Our study revealed that myoferlin loss is significantly correlated with high FIGO grade of endometrioid carcinoma.

Citations

Citations to this article as recorded by  
  • Neoexpression of JUNO in Oral Tumors Is Accompanied with the Complete Suppression of Four Other Genes and Suggests the Application of New Biomarker Tools
    Dominik Kraus, Simone Weider, Rainer Probstmeier, Jochen Winter
    Journal of Personalized Medicine.2022; 12(3): 494.     CrossRef
  • Correlation between myoferlin expression and lymph node metastasis in papillary thyroid carcinoma
    Ji Min Na, Dong Chul Kim, Dae Hyun Song, Hyo Jung An, Hyun Min Koh, Jeong-Hee Lee, Jong Sil Lee, Jung Wook Yang, Min Hye Kim
    Journal of Pathology and Translational Medicine.2022; 56(4): 199.     CrossRef
  • PINCH-1 interacts with myoferlin to promote breast cancer progression and metastasis
    Tao Qian, Chengmin Liu, Yanyan Ding, Chen Guo, Renwei Cai, Xiaoxia Wang, Rong Wang, Kuo Zhang, Li Zhou, Yi Deng, Chuanyue Wu, Ying Sun
    Oncogene.2020; 39(10): 2069.     CrossRef
  • Human colon cancer cells highly express myoferlin to maintain a fit mitochondrial network and escape p53-driven apoptosis
    Gilles Rademaker, Brunella Costanza, Justine Bellier, Michael Herfs, Raphaël Peiffer, Ferman Agirman, Naïma Maloujahmoum, Yvette Habraken, Philippe Delvenne, Akeila Bellahcène, Vincent Castronovo, Olivier Peulen
    Oncogenesis.2019;[Epub]     CrossRef
  • Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression
    Minsun Jung, Cheol Lee, Jeong Hwan Park, Kyung Chul Moon
    Urologic Oncology: Seminars and Original Investigations.2019; 37(11): 812.e9.     CrossRef
  • Ferlin Overview: From Membrane to Cancer Biology
    Peulen, Rademaker, Anania, Turtoi, Bellahcène, Castronovo
    Cells.2019; 8(9): 954.     CrossRef
  • Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers
    Wei Zhu, Bolun Zhou, Chenxuan Zhao, Zhengqing Ba, Hongjuan Xu, Xuejun Yan, Weidong Liu, Bin Zhu, Lei Wang, Caiping Ren
    Journal of Cellular and Molecular Medicine.2019; 23(11): 7180.     CrossRef
  • Myoferlin, a Membrane Protein with Emerging Oncogenic Roles
    Yimin Dong, Honglei Kang, Huiyong Liu, Jia Wang, Qian Guo, Chao Song, Yunlong Sun, Ya Zhang, Honghua Zhang, Zheng Zhang, Hanfeng Guan, Zhong Fang, Feng Li
    BioMed Research International.2019; 2019: 1.     CrossRef
Programmed Death-Ligand 1 Expression and Its Correlation with Lymph Node Metastasis in Papillary Thyroid Carcinoma
Hyo Jung An, Gyung Hyuck Ko, Jeong-Hee Lee, Jong Sil Lee, Dong Chul Kim, Jung Wook Yang, Min Hye Kim, Jin Pyeong Kim, Eun Jung Jung, Dae Hyun Song
J Pathol Transl Med. 2018;52(1):9-13.   Published online October 3, 2017
DOI: https://doi.org/10.4132/jptm.2017.07.26
  • 8,165 View
  • 272 Download
  • 16 Web of Science
  • 13 Crossref
AbstractAbstract PDF
Background
The immunotherapeutic role of programmed death-ligand 1 (PD-L1) in life expectancy in many cancers has been highlighted. However, data regarding PD-L1 expression in papillary thyroid carcinoma (PTC) are limited. In this study, we describe the PD-L1 and programmed cell death protein 1 (PD-1) expressions in PTC and analyze their correlation with lymph node (LN) metastasis.
Methods
Clinicopathological data were obtained from 116 patients with PTC who were treated in Gyeongsang National University Hospital, Jinju, Korea in 2009. Tissue microarray blocks were made using representative paraffin blocks of classical PTCs excluding follicular variants. Two pathologists graded the proportion and intensity of PD-L1 and PD-1 expression in both tumor and inflammatory cells. According to their proportions, positive PTC cells were scored as negative (0%), grade 1 (1%–50%), and grade 2 (51%–100%). Similarly, positive inflammatory cells were graded as negative (0%), grade 1 (1%–10%), and grade 2 (11%–20%). The intensity of each protein expression was simplified as positive or negative.
Results
A statistically significant correlation exists between the proportions of PD-1 and PD-L1 expression both in papillary carcinoma (p=.001) and peritumoral lymphoid cells in the thyroid (p<.001). In addition, the proportion of PD-L1 expression in PTC cells was closely related to metastatic LNs (p=.036).
Conclusions
PD-L1 is a valuable predictive marker for LN metastasis in PTC. Immunomodulating therapies that inhibit PD-L1 might be an option for patients with LN metastasis.

Citations

Citations to this article as recorded by  
  • Chronic Lymphocytic Thyroiditis with Oncocytic Metaplasia Influences PD-L1 Expression in Papillary Thyroid Carcinoma
    Vitor Barreto Santana, Vitória Machado Krüger, Maria Cristina Yunes Abrahão, Pietru Lentz Martins Cantú, Rosicler Luzia Brackmann, Gisele Moroni Pandolfi, Liane Scheffler Marisco, Gabriela Remonatto, Luciana Adolfo Ferreira, Marcia Silveira Graudenz
    Head and Neck Pathology.2024;[Epub]     CrossRef
  • Update regarding the role of PD-L1 in oncocytic thyroid lesions on cytological samples
    Marco Dell'Aquila, Pietro Tralongo, Alessia Granitto, Maurizio Martini, Sara Capodimonti, Mariangela Curatolo, Vincenzo Fiorentino, Alfredo Pontecorvi, Guido Fadda, Celestino Pio Lombardi, Maco Raffaelli, Liron Pantanowitz, Luigi Maria Larocca, Esther Dia
    Journal of Clinical Pathology.2023; 76(10): 671.     CrossRef
  • Analysis of anti‐apoptotic PVT1 oncogene and apoptosis‐related proteins (p53, Bcl2, PD‐1, and PD‐L1) expression in thyroid carcinoma
    Afaf T. Ibrahiem, Amin K. Makhdoom, Khalid S. Alanazi, Abdulaziz M. Alanazi, Abdulaziz M. Mukhlef, Saad H. Elshafey, Eman A. Toraih, Manal S. Fawzy
    Journal of Clinical Laboratory Analysis.2022;[Epub]     CrossRef
  • EphA10 drives tumor progression and immune evasion by regulating the MAPK/ERK cascade in lung adenocarcinoma
    Wenyue Zhao, Lu Liu, Xuehao Li, Shun Xu
    International Immunopharmacology.2022; 110: 109031.     CrossRef
  • Hashimoto’s Thyroiditis Minimizes Lymph Node Metastasis in BRAF Mutant Papillary Thyroid Carcinomas
    Peter P. Issa, Mahmoud Omar, Yusef Buti, Chad P. Issa, Bert Chabot, Christopher J. Carnabatu, Ruhul Munshi, Mohammad Hussein, Mohamed Aboueisha, Mohamed Shama, Ralph L. Corsetti, Eman Toraih, Emad Kandil
    Biomedicines.2022; 10(8): 2051.     CrossRef
  • Expression of β-Catenin in Thyroid Neoplasms (Histopathological and Immunohistochemical Study)
    Mohamed Sherif Ismail, Amr Mousa Abdel Gawad Mousa, Mohammed Faisal Darwish, M. Mostafa Salem, Randa Said
    Open Access Macedonian Journal of Medical Sciences.2022; 10(A): 1565.     CrossRef
  • Identification and validation of an immune-related prognostic signature and key gene in papillary thyroid carcinoma
    Rujia Qin, Chunyan Li, Xuemin Wang, Zhaoming Zhong, Chuanzheng Sun
    Cancer Cell International.2021;[Epub]     CrossRef
  • PD‐L1 and thyroid cytology: A possible diagnostic and prognostic marker
    Marco Dell’Aquila, Alessia Granitto, Maurizio Martini, Sara Capodimonti, Alessandra Cocomazzi, Teresa Musarra, Vincenzo Fiorentino, Alfredo Pontecorvi, Celestino Pio Lombardi, Guido Fadda, Liron Pantanowitz, Luigi Maria Larocca, Esther Diana Rossi
    Cancer Cytopathology.2020; 128(3): 177.     CrossRef
  • Programmed Death-Ligand 1 (PD-L1) Is a Potential Biomarker of Disease-Free Survival in Papillary Thyroid Carcinoma: a Systematic Review and Meta-Analysis of PD-L1 Immunoexpression in Follicular Epithelial Derived Thyroid Carcinoma
    Ilaria Girolami, Liron Pantanowitz, Ozgur Mete, Matteo Brunelli, Stefano Marletta, Chiara Colato, Pierpaolo Trimboli, Anna Crescenzi, Massimo Bongiovanni, Mattia Barbareschi, Albino Eccher
    Endocrine Pathology.2020; 31(3): 291.     CrossRef
  • Regression of Papillary Thyroid Cancer during Nivolumab for Renal Cell Cancer
    Andrea Palermo, Andrea Napolitano, Daria Maggi, Anda Mihaela Naciu, Gaia Tabacco, Silvia Manfrini, Anna Crescenzi, Chiara Taffon, Francesco Pantano, Bruno Vincenzi, Guiseppe Tonini, Daniele Santini
    European Thyroid Journal.2020; 9(3): 157.     CrossRef
  • A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma
    Xian Wang, Shan Huang, Xiaocan Li, Dongrui Jiang, Hongzhen Yu, Qiang Wu, Chaobing Gao, Zhengsheng Wu, Yi-Hsien Hsieh
    PLOS ONE.2018; 13(7): e0200290.     CrossRef
  • Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis
    Daniel Lubin, Ezra Baraban, Amanda Lisby, Sahar Jalali-Farahani, Paul Zhang, Virginia Livolsi
    Endocrine Pathology.2018; 29(4): 317.     CrossRef
  • Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation
    Hoi Yan Ng, Jian Li, Lihua Tao, Alfred King-Yin Lam, Kwok Wah Chan, Josephine Mun Yee Ko, Valen Zhuoyou Yu, Michael Wong, Benjamin Li, Maria Li Lung
    Translational Oncology.2018; 11(6): 1323.     CrossRef
Case Study
Thymoma and Synchronous Primary Mediastinal Seminomas with Florid Follicular Lymphoid Hyperplasia in the Anterior Mediastinum: A Case Report and Review of the Literature
Hyang-im Lee, In-seok Jang, Kyung Nyeo Jeon, Gyung Hyuck Ko, Jong Sil Lee, Dong Chul Kim, Dae Hyun Song, Jeong-Hee Lee
J Pathol Transl Med. 2017;51(2):165-170.   Published online February 2, 2017
DOI: https://doi.org/10.4132/jptm.2016.08.24
  • 8,583 View
  • 136 Download
  • 6 Web of Science
  • 4 Crossref
AbstractAbstract PDF
Thymoma is the most common neoplasm of the anterior mediastinum and has malignant potential. Germ cell tumors (GCTs) found in the anterior mediastinum are usually benign, and malignant GCTs, such as seminomas, are rare. Histologically, mediastinal seminoma is indistinguishable from testicular seminoma except for site-associated morphological features such as lymphoid follicular hyperplasia. Therefore, excluding metastasis is very important. Recently, we treated a young adult patient with multiple thymic masses that occurred simultaneously. The patient underwent a thymectomy for the removal of the mediastinal masses, one of which was diagnosed as type B2 invasive thymoma, and two of which were diagnosed as primary mediastinal seminomas with massive follicular hyperplasia. The patient received adjuvant chemotherapy after surgical resection. To our knowledge, this is the first description of a thymoma and a mediastinal seminoma occurring simultaneously in the thymus. We present this case along with a literature review.

Citations

Citations to this article as recorded by  
  • Primary germ cell tumours of the mediastinum: A review with emphasis on diagnostic challenges
    Alexander Fichtner, Alexander Marx, Philipp Ströbel, Felix Bremmer
    Histopathology.2024; 84(1): 216.     CrossRef
  • Combined Thymic Epithelial Neoplasms – a Review
    Annikka Weissferdt
    International Journal of Surgical Pathology.2023; 31(6): 917.     CrossRef
  • Primary mediastinal seminoma presenting with paraneoplastic anti-Hu encephalitis: a case report and literature review
    Chelsey M. Williams, Derek B. Allison, Adam B. Coleman, Roshmita Bardhan, Jordan D. Miller, Zin W. Myint
    Frontiers in Oncology.2023;[Epub]     CrossRef
  • Primary mediastinal seminoma with florid follicular lymphoid hyperplasia: a case report and review of the literature
    Charlotte Holmes, Peh Sun Loo, Sion Barnard
    Diagnostic Pathology.2021;[Epub]     CrossRef
Brief Case Report
Detection of Human Papillomavirus Type 39 in a Seborrheic Inclusion Cyst of the Buttock
Dae Hyun Song, Sang-Guk Lee, Dong Chul Kim, Jeong Hee Lee, Gyung Hyuck Ko, Jong Sil Lee
Korean J Pathol. 2014;48(5):398-400.   Published online October 27, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.5.398
  • 6,191 View
  • 38 Download
PDF
Original Article
Characteristics of Cutaneous Lymphomas in Korea According to the New WHO-EORTC Classification: Report of a Nationwide Study
Jae Ho Han, Young-Hyeh Ko, Yun Kyung Kang, Wan-Seop Kim, Yoon Jung Kim, Insun Kim, Hyun-Jung Kim, Soo Kee Min, Chan-Kum Park, Chan-Sik Park, Bong-Kyung Shin, Woo Ick Yang, Young-Ha Oh, Jong Sil Lee, Juhie Lee, Tae Hui Lee, Hyekyung Lee, Ho Jung Lee, Yoon Kyung Jeon, Hee Jeong Cha, Yoo-Duk Choi, Chul Woo Kim
Korean J Pathol. 2014;48(2):126-132.   Published online April 28, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.2.126
  • 7,902 View
  • 83 Download
  • 11 Crossref
AbstractAbstract PDF
Background

Previously, cutaneous lymphomas were classified according to either the European Organization for the Research and Treatment of Cancer (EORTC) or the World Health Organization (WHO) classification paradigms. The aim of this study was to determine the relative frequency of Korean cutaneous lymphoma according to the new WHO-EORTC classification system.

Methods

A total of 517 patients were recruited during a recent 5 year-period (2006-2010) from 21 institutes and classified according to the WHO-EORTC criteria.

Results

The patients included 298 males and 219 females, and the mean age at diagnosis was 49 years. The lesions preferentially affected the trunk area (40.2%). The most frequent subtypes in order of decreasing prevalence were mycosis fungoides (22.2%), peripheral T-cell lymphoma (17.2%), CD30+ T-cell lymphoproliferative disorder (13.7%), and extranodal natural killer/T (NK/T) cell lymphoma, nasal type (12.0%). Diffuse large B-cell lymphoma accounted for 11.2% of cases, half of which were secondary cutaneous involvement; other types of B-cell lymphoma accounted for less than 1% of cases.

Conclusions

In comparison with data from Western countries, this study revealed relatively lower rates of mycosis fungoides and B-cell lymphoma in Korean patients, as well as higher rates of subcutaneous panniculitis-like T-cell lymphoma and NK/T cell lymphoma.

Citations

Citations to this article as recorded by  
  • The First Case of Acute Myeloid Leukemia With t(10;11)(p13;q21);PICALM-MLLT10 Rearrangement Presenting With Extensive Skin Involvement
    Min-Seung Park, Hyun-Young Kim, Jae Joon Lee, Duck Cho, Chul Won Jung, Hee-Jin Kim, Sun-Hee Kim
    Annals of Laboratory Medicine.2023; 43(3): 310.     CrossRef
  • Recent advances on cutaneous lymphoma epidemiology
    G. Dobos, M. Miladi, L. Michel, C. Ram-Wolff, M. Battistella, M. Bagot, A. de Masson
    La Presse Médicale.2022; 51(1): 104108.     CrossRef
  • Specific cutaneous infiltrates in patients with haematological neoplasms: a retrospective study with 49 patients
    Rebeca Calado, Maria Relvas, Francisca Morgado, José Carlos Cardoso, Oscar Tellechea
    Australasian Journal of Dermatology.2021;[Epub]     CrossRef
  • Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients
    Gabor Dobos, Anne Pohrt, Caroline Ram-Wolff, Céleste Lebbé, Jean-David Bouaziz, Maxime Battistella, Martine Bagot, Adèle de Masson
    Cancers.2020; 12(10): 2921.     CrossRef
  • Primary cutaneous lymphoma in Argentina: a report of a nationwide study of 416 patients
    Alejandra Abeldaño, Paula Enz, Matias Maskin, Andrea B. Cervini, Natallia Torres, Ana C. Acosta, Marina Narbaitz, Silvia Vanzulli, Mirta Orentrajch, Marta A. Villareal, Maria L. Garcia Pazos, Mariana Arias, Evelyn A. Zambrano Franco, Maria I. Fontana, Rob
    International Journal of Dermatology.2019; 58(4): 449.     CrossRef
  • Post-thymic CD4 positive cytotoxic T cell infiltrates of the skin: A clinical and histomorphologic spectrum of the unique CD4 positive T cell of immunosenescence
    Cynthia M. Magro, Luke C. Olson, Shabnam Momtahen
    Annals of Diagnostic Pathology.2019; 38: 99.     CrossRef
  • Cutaneous lymphomas in Taiwan: A review of 118 cases from a medical center in southern Taiwan
    Chaw-Ning Lee, Chao-Kai Hsu, Kung-Chao Chang, Cheng-Lin Wu, Tsai-Yun Chen, Julia Yu-Yun Lee
    Dermatologica Sinica.2018; 36(1): 16.     CrossRef
  • Imaging analysis of superficial soft tissue lymphomas
    In Sook Lee, You Seon Song, Seung Hyun Lee, Young Jin Choi, Sung Moon Lee
    Clinical Imaging.2018; 49: 111.     CrossRef
  • Epidemiologic, clinical and demographic features of primary cutaneous lymphomas in Castilla‐La Mancha, Spain: are we different?
    C. Ramos‐Rodríguez, M. García‐Rojo, G. Romero‐Aguilera, M. García‐Arpa, L. González‐López, M.P. Sánchez‐Caminero, J. González‐García, M. Delgado‐Portela, M.P. Cortina‐De La Calle, M.F. Relea‐Calatayud, F. Martín‐Dávila, R. López‐Pérez, M. Ramos‐Rodríguez
    Journal of the European Academy of Dermatology and Venereology.2018;[Epub]     CrossRef
  • Nasal-type NK/T-cell lymphomas are more frequently T rather than NK lineage based on T-cell receptor gene, RNA, and protein studies: lineage does not predict clinical behavior
    Mineui Hong, Taehee Lee, So Young Kang, Suk-Jin Kim, Wonseog Kim, Young-Hyeh Ko
    Modern Pathology.2016; 29(5): 430.     CrossRef
  • Cutaneous lymphoma: Kids are not just little people
    Katalin Ferenczi, Hanspaul S. Makkar
    Clinics in Dermatology.2016; 34(6): 749.     CrossRef
Case Study
Large Cell Calcifying Sertoli Cell Tumor of the Testis: A Case Study and Review of the Literature
Dae Hyun Song, Seong Muk Jeong, Jong Tak Park, Gak Won Yun, Byoung Kwon Kim, Jong Sil Lee
Korean J Pathol. 2014;48(1):50-53.   Published online February 25, 2014
DOI: https://doi.org/10.4132/KoreanJPathol.2014.48.1.50
  • 7,821 View
  • 51 Download
  • 5 Crossref
AbstractAbstract PDF

A 24-year-old man was admitted due to an incidentally detected mass in his left testis, which showed radiopaque calcification on plain X-ray film. Left orchiectomy was performed, and the resected testis contained a well-demarcated, hard mass measuring 1.1 cm. Histological analysis revealed that the tumor was composed of neoplastic cells, fibrotic stroma, and laminated or irregularly shaped calcific bodies. The individual cells had abundant eosinophilic or clear cytoplasm with round nuclei, each of which contained one or two conspicuous nucleoli. They were arranged in cords, trabeculae, clusters, and diffuse sheets. There were several foci of intra-tubular growth patterns, with thickening of the basal lamina. Immunohistochemically, the neoplastic cells were positive for S-100 protein and vimentin, focally positive for inhibin alpha, and negative for cytokeratin, CD10, and Melan-A. In addition to reporting this rare case, we also review the relevant literature regarding large cell calcifying Sertoli cell tumors.

Citations

Citations to this article as recorded by  
  • The sclerosing sertoli cell tumor of the testis: a case report
    Xueyao Tang, Yifan Hu, Hong Zhou, Yang Zhou
    Diagnostic Pathology.2023;[Epub]     CrossRef
  • Large Cell Calcifying Sertoli Cell Tumor
    Khaleel I. Al-Obaidy, Muhammad T. Idrees, Eman Abdulfatah, Lakshmi P. Kunju, Angela Wu, Thomas M. Ulbright
    American Journal of Surgical Pathology.2022; 46(5): 688.     CrossRef
  • Intratubular large cell hyalinizing Sertoli cell tumor of the testis presenting with prepubertal gynecomastia: a case report
    Hale Tuhan, Ayhan Abaci, Banu Sarsık, Tülay Öztürk, Mustafa Olguner, Gonul Catli, Ahmet Anik, Nur Olgun, Ece Bober
    Acta Clinica Belgica.2017; 72(4): 254.     CrossRef
  • A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes
    Sarah Scollon, Amanda Knoth Anglin, Martha Thomas, Joyce T. Turner, Kami Wolfe Schneider
    Journal of Genetic Counseling.2017; 26(3): 387.     CrossRef
  • Medical and Surgical Management of Carney Complex
    Juan A. Siordia
    Journal of Cardiac Surgery.2015; 30(7): 560.     CrossRef
Case Report
Osteoclast-like Giant Cell Tumor of Parotid Gland with a Carcinomatous Component: A Case Report
Jung Wook Yang, Hyeon Cheol Kim, Jeong Hee Lee, Jong Sil Lee, Dong Chul Kim, Dae Hyun Song, Jin Pyeong Kim, Gyung Hyuck Ko
Korean J Pathol. 2012;46(3):297-301.   Published online June 22, 2012
DOI: https://doi.org/10.4132/KoreanJPathol.2012.46.3.297
  • 6,811 View
  • 56 Download
  • 5 Crossref
AbstractAbstract PDF

The giant cell tumor of the salivary gland is very rare, and 20 cases have been reported in the English-language literature. We report an additional case. A 57-year old man had noticed a mass in the right parotid area for several weeks. The diagnosis using aspiration cytology was a giant cell tumor possibly with a carcinomatous component. Superficial parotidectomy was carried out. The resected parotid gland contained a 1.8 cm-sized well-circumscribed brownish tumor. Histologically the tumor consisted of evenly distributed osteoclast-like giant cells, mononuclear cells and two small foci of a carcinomatous component. The osteoclast-like giant cells and mononuclear cells were positive for vimentin and CD68, and the carcinomatous component was positive for cytokeratin and epithelial membrane antigen. There was no metastatic lesion in the cervical lymph nodes. We believe this is the first case in Korea of an osteoclast-like giant cell tumor of the parotid gland.

Citations

Citations to this article as recorded by  
  • Genomic alteration in rare subtype of sarcomatoid salivary duct carcinoma
    Ji-Seon Jeong, Kyung-Ja Cho, Deokhoon Kim, Yoon Se Lee, Joon Seon Song
    Pathology - Research and Practice.2021; 228: 153678.     CrossRef
  • Giant cell tumor of temporomandibular joint presenting as a parotid tumor: Challenges in the accurate subclassification of giant cell tumors in an unusual location
    Rongqin Ren, Sandra Mueller, Adele O. Kraft, Celeste N. Powers
    Diagnostic Cytopathology.2018; 46(4): 340.     CrossRef
  • Osteoclast‐Like Giant Cell Tumor of the Parotid Gland: Report of a Case Diagnosed on Fine‐Needle Aspiration Cytology With Histological and Immunohistochemical Findings
    Poonam Elhence, Meenakshi Rao, Amit Goyal, Amit Kumar, Pushpinder S. Khera, Shilajit Bhattacharya
    Diagnostic Cytopathology.2016; 44(6): 548.     CrossRef
  • Giant cell tumour of a temporomandibular joint presenting as a parotid mass: Case report and analysis of the 19 cases in the literature
    Yun-Chen Huang, Jeng-Wen Chen, Yen-Lin Chen, Pei-Jen Lou
    Journal of Cranio-Maxillofacial Surgery.2014; 42(8): 1778.     CrossRef
  • Tumeur à cellules géantes de type ostéoclastique de la parotide
    S. Rammeh, I. Hergli, M.K. M’farrej, N. Znaidi, S. Nechi, R. Zermani
    Revue de Stomatologie, de Chirurgie Maxillo-faciale et de Chirurgie Orale.2014; 115(3): 185.     CrossRef
Original Articles
Insulin-like Growth Factor II mRNA-Binding Protein 3 Expression in Benign and Premalignant Lesions and Carcinomas of the Stomach.
Dae Hyun Song, Jung Wook Yang, Dong Chul Kim, Jong Sil Lee, Jeong Hee Lee, Sang Ho Jeong, Gyung Hyuck Ko
Korean J Pathol. 2011;45(4):379-385.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.4.379
  • 3,235 View
  • 21 Download
  • 2 Crossref
AbstractAbstract PDF
BACKGROUND
Recent studies have demonstrated that insulin-like growth factor II mRNA-binding protein 3 (IMP3) is expressed in malignant tumors of various organs but not in normal tissue. We investigated IMP3 expression in various benign lesions, premalignant lesions and carcinomas of the stomach.
METHODS
IMP3 immunohistochemical staining was performed on 24 benign gastric lesions, 24 gastric adenomas, and 322 gastric carcinomas.
RESULTS
IMP3 was not expressed in benign gastric lesions including adenomas with low-grade dysplasia, but was expressed in 17% of adenomas with high-grade dysplasia, and in 44% of carcinomas. As the carcinomas were in the advanced stage, they expressed IMP3 more frequently and strongly. Patients with IMP3-positive tumors had poorer survival than those with negative tumors.
CONCLUSIONS
IMP3 expression in gastric carcinoma may be related to tumor invasion and metastasis, and is an independent risk factor for poor prognosis.

Citations

Citations to this article as recorded by  
  • IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Ji Young Park, Misun Choe, Yuna Kang, Sang Sook Lee
    Korean Journal of Pathology.2014; 48(2): 108.     CrossRef
  • Role of combination of insulin-like growth factor II messenger RNA-binding protein 3 and claudin-1 immunostaining in differentiation between endometrial endometrioid carcinoma and uterine serous carcinoma
    Maha M. Shamloula, Dareen A. Mohamed, Ayman El-Dorf
    Egyptian Journal of Pathology.2013; 33(2): 237.     CrossRef
WHO Classification of Malignant Lymphomas in Korea: Report of the Third Nationwide Study.
Jin Man Kim, Young Hyeh Ko, Seung Sook Lee, Jooryung Huh, Chang Suk Kang, Chul Woo Kim, Yun Kyung Kang, Jai Hyang Go, Min Kyung Kim, Wan Seop Kim, Yoon Jung Kim, Hyun Jung Kim, Hee Kyung Kim, Jong Hee Nam, Hyung Bae Moon, Chan Kum Park, Tae In Park, Young Ha Oh, Dong Wha Lee, Jong Sil Lee, Juhie Lee, Hyekyung Lee, Sung Chul Lim, Kyu Yun Jang, Hee Kyung Chang, Yoon Kyung Jeon, Hye Ra Jung, Min Sun Cho, Hee Jeong Cha, Suk Jin Choi, Jae Ho Han, Sook Hee Hong, Insun Kim
Korean J Pathol. 2011;45(3):254-260.
DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.3.254
  • 5,793 View
  • 102 Download
  • 65 Crossref
AbstractAbstract PDF
BACKGROUND
The aim of study was to determine the relative frequency of malignant lymphoma according to World Health Organization (WHO) classification in Korea.
METHODS
A total of 3,998 cases diagnosed at 31 institutes between 2005 and 2006 were enrolled. Information including age, gender, pathologic diagnosis, site of involvement and immunophenotypes were obtained.
RESULTS
The relative frequency of non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) was 95.4% and 4.6%, respectively. B-cell lymphomas accounted for 77.6% of all NHL, while T/natural killer (T/NK)-cell lymphomas accounted for 22.4%. The most frequent subtypes of NHL were diffuse large B-cell lymphoma (42.7%), extranodal marginal zone B-cell lymphoma (MZBCL) of mucosa-associated lymphoid tissue (19.0%), NK/T-cell lymphoma (6.3%) and peripheral T-cell lymphoma (PTCL), unspecified (6.3%), in decreasing order. The relative frequency of HL was nodular sclerosis (47.4%), mixed cellularity (30.6%), and nodular lymphocyte predominant (12.1%) subtypes. Compared with a previous study in 1998, increase in gastric MZBCL and nodular sclerosis HL, and slight decrease of follicular lymphoma, PTCL, and NK/T-cell lymphoma were observed.
CONCLUSIONS
Korea had lower rates of HL and follicular lymphoma, and higher rates of extranodal NHL, extranodal MZBCL, and NK/T-cell lymphoma of nasal type compared with Western countries. Changes in the relative frequency of lymphoma subtypes are likely ascribed to refined diagnostic criteria and a change in national health care policy.

Citations

Citations to this article as recorded by  
  • Pattern of Bone Marrow Involvement in B-cell Non-Hodgkin's Lymphoma - Experience from a Tertiary Care Center in North India
    Shareefa Akhter, Nusrat Bashir, MohmadHussain Mir, Fahim Manzoor, Maniza Ayub, MalikTariq Rasool, Sheikh Bilal
    Journal of Radiation and Cancer Research.2023;[Epub]     CrossRef
  • Identification and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing
    Min Ji Jeon, Eun Sang Yu, Chul Won Choi, Dae Sik Kim
    The Korean Journal of Internal Medicine.2023; 38(6): 893.     CrossRef
  • Estimating the global burden of Epstein–Barr virus-related cancers
    Yide Wong, Michael T. Meehan, Scott R. Burrows, Denise L. Doolan, John J. Miles
    Journal of Cancer Research and Clinical Oncology.2022; 148(1): 31.     CrossRef
  • Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study
    Shuo Liu, Weiping Liu, Huichao Li, Lei Yang, Yuqin Song, Xi Zhang, Yangyang Cheng, Qingyu Li, Haoxin Li, Ning Wang, Jun Zhu, Jiafu Ji
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer
    Xinjie Lu
    Current Medicinal Chemistry.2022; 29(41): 6228.     CrossRef
  • Clinical course of duodenal mucosa‐associated lymphoid tissue lymphoma: Comparison with gastric mucosa‐associated lymphoid tissue lymphoma
    Hee Kyong Na, Sung Hyun Won, Ji Yong Ahn, Ga Hee Kim, Kee Wook Jung, Jeong Hoon Lee, Do Hoon Kim, Kee Don Choi, Ho June Song, Gin Hyug Lee, Hwoon‐Yong Jung, Hwa Jung Kim
    Journal of Gastroenterology and Hepatology.2021; 36(2): 406.     CrossRef
  • Real-world data on the survival outcome of patients with newly diagnosed Waldenström macroglobulinemia
    Jang Ho Cho, Joon-Ho Shim, Sang Eun Yoon, Hee-Jin Kim, Sun-Hee Kim, Young Hyeh Ko, Seung-Tae Lee, Kihyun Kim, Won Seog Kim, Seok Jin Kim
    The Korean Journal of Internal Medicine.2021; 36(3): 668.     CrossRef
  • Primary Gastrointestinal T/NK Cell Lymphoma
    Eun Kyung Kim, Mi Jang, Woo Ick Yang, Sun Och Yoon
    Cancers.2021; 13(11): 2679.     CrossRef
  • Mucosa-Associated Lymphoid Tissue Lymphoma of the Cheek Mimicking Benign Entities: a Case Report
    Hyun Hwang, Jae Ho Shin, Yon Kwon Ihn, Sungjun Han, Hong Sik Park
    Investigative Magnetic Resonance Imaging.2021; 25(2): 129.     CrossRef
  • Classification of non-Hodgkin lymphoma in the Middle Euphrates Region of Iraq according to the World Health Organization classification
    Ahmed Mjali, AlyaaHadi Oudah, HaiderHasan Jaleel Al-Shammari, NareenTawfeeq Abbas
    Iraqi Journal of Hematology.2021; 10(2): 170.     CrossRef
  • Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting
    Jeffrey I. Cohen, Keiji Iwatsuki, Young-Hyeh Ko, Hiroshi Kimura, Irini Manoli, Koichi Ohshima, Stefania Pittaluga, Leticia Quintanilla-Martinez, Elaine S. Jaffe
    Leukemia & Lymphoma.2020; 61(4): 808.     CrossRef
  • Cutaneous lymphoma in Japan, 2012–2017: A nationwide study
    Kazuyasu Fujii, Toshihisa Hamada, Takatoshi Shimauchi, Jun Asai, Yasuhiro Fujisawa, Hironobu Ihn, Norito Katoh
    Journal of Dermatological Science.2020; 97(3): 187.     CrossRef
  • Practical Approach to the Histologic Diagnosis of Gastrointestinal Lymphomas Through the First-line Marker Battery of CD20, CD3, CD30, and Epstein-Barr Virus–encoded RNAs
    Eun Kyung Kim, Woo Ick Yang, Hyang Joo Ryu, Hee Lee Ji, Sun Och Yoon
    Advances in Anatomic Pathology.2020; 27(2): 75.     CrossRef
  • Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group
    Dok Hyun Yoon, Junning Cao, Tsai-Yun Chen, Koji Izutsu, Seok Jin Kim, Yok Lam Kwong, Tong Yu Lin, Lim Soon Thye, Bing Xu, Deok Hwan Yang, Won Seog Kim
    Journal of Hematology & Oncology.2020;[Epub]     CrossRef
  • Morphologic variant of follicular lymphoma reminiscent of hyaline-vascular Castleman disease
    Jiwon Koh, Yoon Kyung Jeon
    Journal of Pathology and Translational Medicine.2020; 54(3): 253.     CrossRef
  • Discovery of Novel Recurrent Mutations and Clinically Meaningful Subgroups in Nodal Marginal Zone Lymphoma
    Jiwon Koh, Insoon Jang, Seongmin Choi, Sehui Kim, Ingeon Jang, Hyun Kyung Ahn, Cheol Lee, Jin Ho Paik, Chul Woo Kim, Megan S. Lim, Kwangsoo Kim, Yoon Kyung Jeon
    Cancers.2020; 12(6): 1669.     CrossRef
  • Clinicopathological and Immunophenotype Spectrum of Malignant Lymphoma in Eastern India Population – A Tertiary Care Hospital Study
    Debahuti Mohapatra, Rajashree Tripathy, Prateek Das, Pallak Batalia
    Journal of Evidence Based Medicine and Healthcare.2020; 7(38): 2120.     CrossRef
  • Cost-utility analysis of pralatrexate for relapsed or refractory peripheral T-cell lymphoma based on a case-matched historical control study along with single arm clinical trial
    Seonyoung Park, Ah-Young Kim, Hyeonseok Cho, Deborah Baik, Hankil Lee, Sunghwa Cho, Hye-Young Kang
    BMC Cancer.2020;[Epub]     CrossRef
  • Extranodal non-Hodgkin’s lymphoma: A case series at a tertiary care hospital
    Pomilla Singh, Ravi Swami, Shashank Singh, N S Mani, M N Karandikar
    IP Archives of Cytology and Histopathology Research.2020; 5(4): 302.     CrossRef
  • Pediatric non‐Hodgkin lymphoma: Characteristics, stratification, and treatment at a single institute in Thailand
    Worawut Choeyprasert, Usanarat Anurathapan, Samart Pakakasama, Nongnuch Sirachainan, Duantida Songdej, Surapong Lertthammakiat, Suradej Hongeng
    Pediatrics International.2019; 61(1): 49.     CrossRef
  • Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
    Wook Youn Kim, Ivonne A. Montes-Mojarro, Falko Fend, Leticia Quintanilla-Martinez
    Frontiers in Pediatrics.2019;[Epub]     CrossRef
  • Chimeric Antigen Receptor T-Cell Therapy for Diffuse Large B-Cell Lymphoma
    Heejung Chae, Dok Hyun Yoon
    The Korean Journal of Medicine.2019; 94(2): 152.     CrossRef
  • Classification of malignant lymphoma subtypes in Korean patients: a report of the 4th nationwide study
    Hye-Ra Jung, Jooryung Huh, Young-Hyeh Ko, Yoon Kyung Jeon, Sun Och Yoon, Se Hoon Kim, Woo Ick Yang, Geongsin Park, Jo Heon Kim, Jin Ho Paik, Jae Ho Han, Hee Jung Cha, Kyu Yun Jang, Bong-Kyung Shin, Young-A Kim, Ji Eun Kim, Yoo Duk Choi, Min Gyoung Park, H
    Journal of Hematopathology.2019; 12(4): 173.     CrossRef
  • Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study
    Sung Yong Oh, Won Seog Kim, Jin Seok Kim, Seok Jin Kim, Dok Hyun Yoon, Deok‐Hwan Yang, Won Sik Lee, Hyo Jung Kim, Ho‐Young Yhim, Seong Hyun Jeong, Jong Ho Won, Suee Lee, Jee Hyun Kong, Sung‐Nam Lim, Jun Ho Ji, Kyung A. Kwon, Gyeong‐Won Lee, Jae Hoon Lee,
    Cancer Communications.2019; 39(1): 1.     CrossRef
  • Changing trends in lymphoid neoplasm distribution in South Korea: analysis of 8615 cases from a single institute, 1997–2016
    Jongmin Sim, Takuya Takayama, Junhun Cho, Seok Jin Kim, Won Seog Kim, Howe J. Ree, Young Hyeh Ko
    Medicine.2019; 98(45): e17641.     CrossRef
  • Non‐Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand
    Tanin Intragumtornchai, Udomsak Bunworasate, Kitsada Wudhikarn, Arnuparp Lekhakula, Jakrawadi Julamanee, Kanchana Chansung, Chittima Sirijerachai, Lalita Norasetthada, Weerasak Nawarawong, Archrob Khuhapinant, Noppadol Siritanaratanakul, Tontanai Numbenja
    Hematological Oncology.2018; 36(1): 28.     CrossRef
  • Prevalence and Implications of Bone Marrow Involvement in Patients with Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
    Sang Il Choi, Myeong-Cherl Kook, Sanghyun Hwang, Young-Il Kim, Jong Yeul Lee, Chan Gyoo Kim, Il Ju Choi, Hyewon Lee, Hyeon Seok Eom, Soo-Jeong Cho
    Gut and Liver.2018; 12(3): 278.     CrossRef
  • A Case of Synchronous Lung Squamous Cell Carcinoma and Diffuse Large B-cell Lymphoma
    Seung Jae Lee, Si Young Lim, Tae Kyung Yoo, Seul Ki Kim, You Gyung Kim, Hyun Joo Lee, Jae Uk Song
    The Korean Journal of Medicine.2018; 93(3): 300.     CrossRef
  • A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
    Ho-Young Yhim, Yong Park, Yeon-Hee Han, Sungeun Kim, Sae-Ryung Kang, Joon-Ho Moon, Ju Hye Jeong, Ho-Jin Shin, Keunyoung Kim, Yoon Seok Choi, Kunho Kim, Min Kyoung Kim, Eunjung Kong, Dae Sik Kim, Jae Seon Eo, Ji Hyun Lee, Do-Young Kang, Won Sik Lee, Seok M
    European Journal of Nuclear Medicine and Molecular Imaging.2018; 45(13): 2274.     CrossRef
  • Low-grade follicular lymphoma involvement of the bone marrow with a mixed paratrabecular, diffuse, and massive pattern expressing typical mantle cell lymphoma immunophenotype CD23−/FMC7+: a case report
    Jaewook Kim, Ji-Hun Lim, Joseph Jeong, Seon-Ho Lee, Jae-Cheol Jo, Sang Hyuk Park
    Blood Research.2018; 53(3): 261.     CrossRef
  • Aspectos epidemiológicos, clínicos e anatomopatológicos do linfoma folicular em cães
    Renata D. Mazaro, Isis P.J. Rizkallah, Flávia S. Luz, Douglas M. Lorensetti, Bruno Cogliati, Rafael A. Fighera
    Pesquisa Veterinária Brasileira.2018; 38(9): 1772.     CrossRef
  • Serious fungal infections in Korea
    K. Huh, Y. E. Ha, D. W. Denning, K. R. Peck
    European Journal of Clinical Microbiology & Infectious Diseases.2017; 36(6): 957.     CrossRef
  • Epidural Lymphoma Mimicking Hematoma: A Case Report
    Dong-Yeong Lee, Soon-Taek Jeong, Kun-Tae Kim, Jung-Wook Yang, Dong-Hee Kim
    Journal of Korean Society of Spine Surgery.2017; 24(1): 49.     CrossRef
  • Geographical Correlations between Indoor Radon Concentration and Risks of Lung Cancer, Non-Hodgkin’s Lymphoma, and Leukemia during 1999–2008 in Korea
    Mina Ha, Seung-sik Hwang, Sungchan Kang, No-Wook Park, Byung-Uck Chang, Yongjae Kim
    International Journal of Environmental Research and Public Health.2017; 14(4): 344.     CrossRef
  • Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improvi
    Jeongkuk Seo, Won Seog Kim, Jin Seok Kim, Seok Jin Kim, Jae Hoon Lee, Jun Shik Hong, Gyeong-Won Lee, Sung Yong Oh, Ji-Hyun Lee, Dok Hyun Yoon, Won-Sik Lee, Hyo Jung Kim, Jae-Yong Kwak, Hye Jin Kang, Jae-Cheol Jo, Yong Park, Ho Sup Lee, Hyo-Jin Kim, Cheolw
    Blood Research.2017; 52(3): 200.     CrossRef
  • Treatment outcome and risk analysis for cataract after radiotherapy of localized ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma
    Hee Hyun Park, Sea-Won Lee, Soo Yoon Sung, Byung Ock Choi
    Radiation Oncology Journal.2017; 35(3): 249.     CrossRef
  • The prognostic significance of CD11b+CX3CR1+ monocytes in patients with newly diagnosed diffuse large B-cell lymphoma
    Ho-Young Yhim, Jeong-A Kim, Sun-Hye Ko, Youngrok Park, Eunjung Yim, Hee Sun Kim, Jae-Yong Kwak
    Oncotarget.2017; 8(54): 92289.     CrossRef
  • Epidural Lymphoma Mimicking Hematoma: A Case Report
    Dong-Yeong Lee, Soon-Taek Jeong, Kun-Tae Kim, Jung-Wook Yang, Dong-Hee Kim
    Journal of Korean Society of Spine Surgery.2017; 24(1): 49.     CrossRef
  • A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trial
    Sung Yong Oh, Won Seog Kim, Jin Seok Kim, Yee Soo Chae, Gyeong-Won Lee, Hyeon Seok Eom, Hun Mo Ryoo, Suee Lee, Seok Jin Kim, Dok Hyun Yoon, Jong Ho Won, Junshik Hong, Jinny Park, Sang-Min Lee, Jung Yong Hong, Eunkyung Park, Hyo Jung Kim, Deok-Hwan Yang, H
    Leukemia & Lymphoma.2016; 57(6): 1406.     CrossRef
  • Diffuse Large B-Cell Lymphoma of the Peri-Implant Mucosa Mimicking Peri-Implantitis
    Seong-Ho Jin, Gyeongsin Park, Youngkyung Ko, Jun-Beom Park
    Journal of Oral Implantology.2016; 42(2): 220.     CrossRef
  • The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma
    Tae Hyung Kim, Jin Seok Kim, Yang-Gun Suh, Jaeho Cho, Woo-Ick Yang, Chang-Ok Suh
    Yonsei Medical Journal.2016; 57(4): 846.     CrossRef
  • Treatment outcomes of IMEP as a front-line chemotherapy for patients with peripheral T-cell lymphomas
    Ji Young Lee, Sang Min Lee, Moon Young Choi, Ki Hyang Kim, Young Don Joo, Sung Nam Im, Won Sik Lee
    Blood Research.2016; 51(3): 187.     CrossRef
  • Immune reconstitution inflammatory syndrome versus non-immune reconstitution inflammatory syndrome lymphoma in HIV patients on antiretroviral therapy
    Pyoeng Gyun Choe, Jinyong Park, Wan Beom Park, Tae Min Kim, Kyoung-Ho Song, Ji Hwan Bang, Eu Suk Kim, Sang Won Park, Hong Bin Kim, Nam Joong Kim, Myoung-don Oh, Kang Won Choe
    International Journal of STD & AIDS.2016; 27(11): 1013.     CrossRef
  • Clinical outcome and prognosis of patients with primary sinonasal tract diffuse large B-cell lymphoma treated with rituximab-cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy: a study by the Consortium for Improving Survival of Lympho
    Gyeong-Won Lee, Se-Il Go, Seok-Hyun Kim, Junshik Hong, Yu Ri Kim, Sukjoong Oh, Sung-Yong Kim, Young Rok Do, Hyewon Lee, Soon Il Lee, Sung Hwa Bae, Sung Yong Oh, Moo Kon Song, Won-Sik Lee, Bohee Lee, Jin Seok Kim, Min Kyoung Kim, Hye Jin Kang, Jae-Sook Ahn
    Leukemia & Lymphoma.2015; 56(4): 1020.     CrossRef
  • Therapeutic comparison of Surgery combined with chemotherapy and chemotherapy alone for Primary Gastrointestinal Lymphoma: A single center study
    Je Hun Kim, Ho Sup Lee, Jun Seop Lee, Jin Young Lee, Su Young Kim, Cheol Su Kim, Joung Wook Yang, Ga In You
    Kosin Medical Journal.2015; 30(1): 29.     CrossRef
  • A Case of Simultaneous Primary Gastric and Duodenal Mucosa-Associated Lymphoid Tissue Lymphoma after Therapeutic Endoscopy
    Sun Hee Park, Jae Young Jang, Min A Park, Hyuck Kim, Young Woon Chang
    Korean Journal of Medicine.2015; 89(1): 64.     CrossRef
  • Clinicopathologic Study of Chromosomal Aberrations in Ocular Adnexal Lymphomas of Korean Patients
    Hokyung Choung, Young A Kim, Namju Kim, Min Joung Lee, Sang In Khwarg
    Korean Journal of Ophthalmology.2015; 29(5): 285.     CrossRef
  • A Rare Case of Malignant Lymphoma Occurred at Spinal Epidural Space: A Case Report
    Hyun-Jun Cho, Jang-Bo Lee, Junseok W. Hur, Sung-Won Jin, Tai-Hyoung Cho, Jung-Yul Park
    Korean Journal of Spine.2015; 12(3): 177.     CrossRef
  • Radiotherapy as an effective treatment modality for follicular lymphoma: a single institution experience
    Seo Hee Choi, Jaeho Cho, Jin Seok Kim, June-Won Cheong, Chang-Ok Suh
    Radiation Oncology Journal.2015; 33(4): 310.     CrossRef
  • Current therapy of choice for cutaneous lymphomas: Complementary to the Japanese Dermatological Association/Japanese Skin Cancer Society guidelines
    Keiji Iwatsuki, Toshihisa Hamada
    The Journal of Dermatology.2014; 41(1): 43.     CrossRef
  • The Role of Radiotherapy in the Treatment of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
    Taek-Keun Nam, Jae-Sook Ahn, Yoo-Duk Choi, Jae-Uk Jeong, Yong-Hyeob Kim, Mee Sun Yoon, Ju-Young Song, Sung-Ja Ahn, Woong-Ki Chung
    Cancer Research and Treatment.2014; 46(1): 33.     CrossRef
  • Current Concepts in Primary Effusion Lymphoma and Other Effusion-Based Lymphomas
    Yoonjung Kim, Chan Jeong Park, Jin Roh, Jooryung Huh
    Korean Journal of Pathology.2014; 48(2): 81.     CrossRef
  • Benign Indolent CD56-Positive NK-Cell Lymphoproliferative Lesion Involving Gastrointestinal Tract in an Adolescent
    Jaemoon Koh, Heounjeong Go, Won Ae Lee, Yoon Kyung Jeon
    Korean Journal of Pathology.2014; 48(1): 73.     CrossRef
  • Peripheral T cell lymphoma in Asia
    Sanghui Park, Young Hyeh Ko
    International Journal of Hematology.2014; 99(3): 227.     CrossRef
  • Characteristics of Cutaneous Lymphomas in Korea According to the New WHO-EORTC Classification: Report of a Nationwide Study
    Jae Ho Han, Young-Hyeh Ko, Yun Kyung Kang, Wan-Seop Kim, Yoon Jung Kim, Insun Kim, Hyun-Jung Kim, Soo Kee Min, Chan-Kum Park, Chan-Sik Park, Bong-Kyung Shin, Woo Ick Yang, Young-Ha Oh, Jong Sil Lee, Juhie Lee, Tae Hui Lee, Hyekyung Lee, Ho Jung Lee, Yoon
    Korean Journal of Pathology.2014; 48(2): 126.     CrossRef
  • Epstein–Barr virus‐associated T/natural killer‐cell lymphoproliferative disorders
    Sanghui Park, Young H. Ko
    The Journal of Dermatology.2014; 41(1): 29.     CrossRef
  • Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas
    Jin Ho Paik, Soo Jeong Nam, Tae Min Kim, Dae Seog Heo, Chul-Woo Kim, Yoon Kyung Jeon
    BMC Cancer.2014;[Epub]     CrossRef
  • Clinicopathologic implication of A20/TNFAIP3 deletion in diffuse large B-cell lymphoma: an analysis according to immunohistochemical subgroups and rituximab treatment
    Jin Ho Paik, Heounjeong Go, Soo Jeong Nam, Tae Min Kim, Dae Seog Heo, Chul-Woo Kim, Yoon Kyung Jeon
    Leukemia & Lymphoma.2013; 54(9): 1934.     CrossRef
  • Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party Registry
    Hyeon Gyu Yi, Jin Seok Kim, Cheolwon Suh, Won Seog Kim, Jae-Yong Kwak, Jong-Seok Lee, Yang Soo Kim, Young Don Joo, Yoo Hong Min, Hong Ghi Lee, Sung-Soo Yoon, Jong-Ho Won, Seonyang Park, Hugh Chul Kim, Chul Soo Kim
    Blood Research.2013; 48(2): 115.     CrossRef
  • Epidemiologic overview of malignant lymphoma
    Jooryung Huh
    The Korean Journal of Hematology.2012; 47(2): 92.     CrossRef
  • Gastrointestinal Lymphoma
    Yoon Jung Lee, Jun Haeng Lee
    The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2012; 12(3): 158.     CrossRef
  • Transformation of CD5-Negative Follicular Lymphoma into CD5-Positive Diffuse Large B-Cell Lymphoma: A Case Report
    Hyeong Kug Kim, In Sung Cho, Hye Kyung Lee, Yong Hun Choi, Seong Min Cho, Hyun Jin Moon, Jin A Lee
    Korean Journal of Medicine.2012; 83(2): 263.     CrossRef
  • The Role of Radiotherapy for the Treatment of Gastric MALT Lymphoma
    Jae-Sook Ahn, Taek-Keun Nam
    Korean Journal of Medicine.2012; 83(6): 712.     CrossRef
  • Pathophysiology of Gastric MALT Lymphoma
    Gyeongsin Park, Chang Suk Kang
    Korean Journal of Medicine.2012; 83(6): 689.     CrossRef
  • CD44s and CD44v6 Are Predominantly Expressed in the Non-germinal Center B-Cell-like Type of Diffuse Large B-Cell Lymphomas
    Kyueng-Whan Min, Young-Ha Oh, Chan-Kum Park, So-Dug Lim, Wan-Seop Kim
    The Korean Journal of Pathology.2011; 45(6): 589.     CrossRef
IMP3 Expression of the Cholangiocarcinoma in Cytology Specimen and Its Diagnostic Value.
Jung Wook Yang, Jong Sil Lee, Dong Chul Kim, Dae Hyun Song, Gyung Hyuck Ko, Jeong Hee Lee
Korean J Pathol. 2010;44(6):642-650.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.6.642
  • 3,679 View
  • 28 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
Pathologists occasionally have difficulty in distinguishing cholangiocarcinoma from benign reactive cells on the biliary cytology. We estimated the diagnostic value of insulinlike growth factor II mRNA binding protein 3 (IMP3) on biliary cytology specimens.
METHODS
We selected 40 patients who had undergone a biliary cytology examination and whose diagnoses were confirmed by biopsy. The IMP3 expression was evaluated by immunohistochemical staining in both the tissue and the cytology specimens. Their histologic diagnoses were cholangiocarcinoma (n = 34), high grade dysplasia (n = 2), low grade dysplasia (n = 1) and non-biliary tumor or no tumor (n = 3).
RESULTS
On the histology, all the cases of cholangiocarcinoma or high grade dysplasia were positive for IMP3 (36/36). The low grade dysplasia or the normal bile ducts in the other 4 cases were negative for IMP3 (0/4). Of the 36 cases diagnosed as cholangiocarcinoma or high grade dysplasia histologically, 29 cases were positive for IMP3 on the cytology (29/36; sensitivity, 80.6%). Of the 4 cases without cholangiocarcinoma or high grade dysplasia, 1 case was weakly positive for IMP3 on the cytology. The histologic diagnosis of this case was hepatocellular carcinoma. Except for this hepatocellular carcinoma case, the specificity of IMP3 on the cytology was 100%.
CONCLUSIONS
IMP3 is a useful diagnostic marker for cholangiocarcinoma on cytology.

Citations

Citations to this article as recorded by  
  • Insulin-like Growth Factor II mRNA-Binding Protein 3 Expression in Benign and Premalignant Lesions and Carcinomas of the Stomach
    Dae Hyun Song, Jung Wook Yang, Dong Chul Kim, Jong Sil Lee, Jeong Hee Lee, Sang Ho Jeong, Gyung Hyuck Ko
    The Korean Journal of Pathology.2011; 45(4): 379.     CrossRef
Korean Pediatric/Adolescent Lymphoma: Incidence and Pathologic Characteristics.
Seung Sook Lee, Jin Man Kim, Young Hyeh Ko, Jooryung Huh, Chang Suk Kang, Chul Woo Kim, Yun Kyung Kang, Jai Hyang Go, Min Kyung Kim, Wan Seop Kim, Yoon Jung Kim, Hyun Jung Kim, Hee Kyung Kim, Jong Hee Nam, Hyung Bae Moon, Chan Kum Park, Tae In Park, Young Ha Oh, Dong Wha Lee, Jong Sil Lee, Juhie Lee, Hyekyung Lee, Sung Chul Lim, Kyu Yun Jang, Hee Kyung Chang, Yoon Kyung Jeon, Hye Ra Jung, Min Sun Cho, Hee Jeong Cha, Suk Jin Choi, Jae Ho Han, Sook Hee Hong, Insun Kim
Korean J Pathol. 2010;44(2):117-124.
DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.2.117
  • 4,019 View
  • 37 Download
  • 1 Crossref
AbstractAbstract PDF
BACKGROUND
The Hematopathology Study Group of the Korean Society of Pathologists conducted a nation-wide retrospective analysis of Korean pediatric lymphoma, to provide pathologic data on pediatric/adolescent lymphoma subtypes and features.
METHODS
All lymphoma cases of all age groups were collected during a recent 2 year-period (2005-2006) from 32 institutes in Korea. Among 3,686 lymphoma patients, 142 who were age 18 or less were classified according to the World Health Organization (WHO) classification.
RESULTS
Among 142 pediatric/adolescent lymphoma patients, Hodgkin lymphoma accounted for 21 (14.8%) and non-Hodgkin lymphoma (NHL) for 121 (85.2%). Hodgkin lymphoma appears to be more common in the pediatric/adolescent age group than in the all-ages group (14.8% vs 4.4%). T- and natural killer cell-NHL was more common in the pediatric/adolescent age group than in the all ages group (46.3% vs 22%). The majority of Korean pediatric/adolescent NHL cases was composed of Burkitt lymphoma, T- or B-lymphoblastic lymphoma, anaplastic large-cell lymphoma, and diffuse large B-cell lymphoma. For lymphoma patients under the age of 6 years, most had B-lymphoblastic or Burkitt lymphoma, which commonly presented at extranodal sites.
CONCLUSIONS
The distribution of lymphoma subtypes in the pediatric/adolescent age group is quite different from the distribution of adults, but it was quite similar to distribution in Western countries.

Citations

Citations to this article as recorded by  
  • A Case of Nasal Type Extranodal NK/T Cell Lymphoma Incidentally Detected in a Child
    Ha Jin Oh, Sang Hyun Park, Hae In Jang, Dong Hoon Lee, Yoo Duk Choi, Hee Jo Baek, Hoon Kook
    Clinical Pediatric Hematology-Oncology.2015; 22(1): 76.     CrossRef
Case Report
Epithelioid Angiomyolipoma of the Kidney: A case report.
You Kyung Kim, Jong Sil Lee, Ky Hyun Chung, Sun Hoo Park, Gyung Hyuck Ko
Korean J Pathol. 2000;34(11):953-956.
  • 1,443 View
  • 12 Download
AbstractAbstract PDF
Angiomyolipoma is considered by many authors to be a hamartoma, occurring in a sporadic form or in association with tuberous sclerosis. This lesion consists of thick walled blood vessels, smooth muscle, and mature adipose tissue in varying amounts. We have experienced a case of the angiomyolipoma composed of monotypic epithelioid cells. The patient was a 69-year-old female. Clinically, there was no evidence of tuberous sclerosis. Microscopically, the tumor was composed of polygonal cells with abundant eosinophilic granular or clear cytoplasm, pleomorphic nuclei, prominent nucleoli, and multinucleated giant cells. The tumor cells showed positive reaction for HMB45, CD68, smooth muscle actin, and S-100, and negative reaction for epithelial membrane antigen, cytokeratin, vimentin, desmin, CD34, estrogen receptor, and progesterone receptor. Ultrastructual analysis showed the presence of glycogen, mitochondria, and other microorganelles in neoplastic cells. Melanosome or premelanosome was not identified.

J Pathol Transl Med : Journal of Pathology and Translational Medicine